Medios AG

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on onco…

Medical - Distribution

DE, Berlin [HQ]

FA

Fundamental Analysis · Most Recent Quarter

A dedicated fundamental analysis might help you to get a quick overview
of the financial stability. It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale

Framework:

Valuation n.A. n.A.

Profitability n.A. n.A.

Fin. Growth n.A. n.A.

Leverage & Liquidity n.A. n.A.

Per Share Metrics n.A. n.A.

Fin. Health n.A. n.A.

1 Financial Health

Metric	Q₃	Q₄	Δ in %
Current Ratio	n.A.	n.A.	n.A.
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	n.A.	n.A.	n.A.
Naive Interpretation	member

2 Per Share

Metric	Q₃	Q₄	Δ in %
Book Value	n.A.	n.A.	n.A.
Cash	n.A.	n.A.	n.A.
Capex	n.A.	n.A.	n.A.
Free Cash Flow	n.A.	n.A.	n.A.
Revenue	n.A.	n.A.	n.A.
Naive Interpretation	member

3 Profitability

Metric	Q₃	Q₄	Δ in %
Gross Margin	n.A.	n.A.	n.A.
Operating Margin	n.A.	n.A.	n.A.
ROA	n.A.	n.A.	n.A.
ROE	n.A.	n.A.	n.A.
ROIC	n.A.	n.A.	n.A.
Naive Interpretation	member

4 Valuation

The "Valuation Entry" for the Focus of MEDOF is permitted for members.

5 Growth

The "Growth Entry" for the Focus of MEDOF is permitted for members.

6 Leverage & Liquidity

FA

The "Valuation Entry" for the Focus of MEDOF is permitted for members.

The "Growth Entry" for the Focus of MEDOF is permitted for members.

The "Leverage & Liquidity Entry" for the Focus of MEDOF is permitted for members.